학술논문
TREATMENT RETENTION AND SAFETY OF IXEKIZUMAB IN A POPULATION WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC AND TARGETED SYNTHETIC DMARDS.
Document Type
Article
Author
Source
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1783-1783, 2/3p
Subject
Language
ISSN
00034967